WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2025ACC: 0001415889-25-022803
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-15.39K
Net shares
Net seller
$206.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
15.39K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−15.39K
Price / share
$13.39
Trade value
$206.13K
% of position
0.9%
8/20/2025
1.73M→1.72M
Total
Net shares
−15.39K
Net value
-$206.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2025 | F · Tax Withholding | −15.39K | $13.39 | $206.13K | 0.9% | 1.73M | 1.72M |
| Total | −15.39K | -$206.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned92.57K
Ordinary Shares
IndirectShares owned13.50K
Total
106.07K indirect106.07K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Ordinary Shares | 13.50K | Indirect |
| Total | 106.07K | 106.07K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported